Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Study of Huntington disease by analyzing RNA-Seq data using fly and mouse models

ABSTRACT: In this study, we perform deep mRNA sequencing to study the effect of a few gene modifiers in Huntington disease using fly models. Analysis of 3 fly RNA-Seq samples and 4 mouse RNA-Seq samples

ORGANISM(S): Mus musculus

SUBMITTER: hao zhao

PROVIDER: E-GEOD-32192 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Study of Huntington disease by analyzing RNA-Seq data using fly and mouse models

Project description:In this study, we perform deep mRNA sequencing to study the effect of a few gene modifiers in Huntington disease using fly models.

2014-09-05 | GSE32192 | GEO

Study of Huntington disease by analyzing RNA-Seq data using fly and mouse models

Project description:Study of Huntington disease by analyzing RNA-Seq data using fly and mouse models

| PRJNA147407 | ENA

Expression data from human Huntington fibroblasts

2013-03-28 | GSE45516 | GEO

Expression data from human Huntington fibroblasts

Project description:Gene expression profile comparison from fibroblasts of Huntington individuals and normal ones We used microarrays to detail the global gene expression of fibroblasts from Huntington patients Comparison between six Huntington human fibroblasts and three normal controls. All individuals were aged and sex matched. In fact they are all males with the subsequent ages: 28, 48, 57 for the controls and 38, 63, 57, 47, 38, 37 for the HD patients. The average age is comparable.

2013-03-28 | E-GEOD-45516 | biostudies-arrayexpress

Huntington disease protein accelerates tumour development and metastasis

Project description:Huntington disease is a severe neurological disorder caused by an abnormal polyglutamine expansion in the N-terminal of the huntingtin protein. Here we show that breast tumours appear earlier when mutant huntingtin is expressed in an activated polyomavirus middle T antigen (PyVT) mouse breast cancer model as compared to the control mice expressing wild-type huntingtin. Tumours bearing mutant huntingtin have a modified gene expression pattern revealing increases in the IGF-1/Akt signalling, epithelial-mesenchymal transition and metastatic properties. Indeed, polyQ-huntingtin expressing tumours show hyper-activation of Akt pathway. Also, when mutant huntingtin is expressed, cancer cells in culture change morphology and the levels of cell adhesion and mesenchymal markers are affected in primary tumour or corresponding derived cells. As a consequence, PyVT induced lung metastasis is higher in Huntington disease mice than in the control mice. Finally, analysis of cases of Huntington disease patients developing breast cancer may suggest an increased aggressiveness of breast cancer when compared to the control population. 8 Total samples were analyzed: 4 x MMTV-PyVT/HdhQ7/Q7 breast tumours; 4 x MMTV-PyVT/HdhQ111/Q111 breast tumours;

2014-04-14 | E-GEOD-28685 | biostudies-arrayexpress

Huntington disease protein accelerates tumour development and metastasis

2014-04-14 | GSE28685 | GEO

miRNA Expression from Cerebrospinal Fluid (CSF) from Prodromal Huntington Disease Patients

Project description:Analysis of microRNA (miRNA) expression in CSF from prodromal Huntington disease patients.

2020-05-10 | GSE150174 | GEO

Gene Expression Profiling Using Huntington Disease Cell Culture Model

Project description:To identify genes affected by mutant huntington protein, we performed mRNA-seq experiments with Striatal STHdh Q7/Q7, Q7Q111, and Q111/Q111 cells. We also tested the effect of Sp1 overexpression on rescuing gene expression in Q111/Q111 cells.

2016-07-15 | GSE84055 | GEO

Transcriptome analysis of Huntington disease and control cerebral organoids at day 45 and 105 of differentiation

Project description:We compared transcriptional profile of organoids derived from iPS lines of a Huntington patient (Q109) and CTR (Q21) at day 45 and day 105 of differentiation.

2018-04-05 | E-MTAB-5964 | biostudies-arrayexpress

Circulating non-coding RNAs in Huntington disease

Project description:Circulating non-coding RNAs in Huntington disease

| PRJNA705157 | ENA